Dimetotiazine Mesilate

甲磺酸二甲替嗪

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDimetotiazine Mesilate
Drug Alias Namedimetotiazina甲磺二甲替嗪dimetotiazinumBanistylTonlipin +[7
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsHeadacheHypersensitivityPruritus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsHeadacheHypersensitivityPruritus
Inactive IndicationsN/A

Other Information

ATC CodeN02CX05